The legacy success of sildenafil has undeniably transformed the drug landscape. However, investing in companies heavily reliant on generic versions and the declining patent protection surrounding this https://meshbookmarks.com/story21472945/the-blue-pill-and-drugmakers-a-uncertain-investment